LITS

Lite Strategy Inc. Common Stock (LITS)

Stock · NASDAQ · Health Care

$0.98as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$1.16
Industry
Biotechnology: Pharmaceutical Preparations

Fundamentals

Market cap
$33.39M
P/E (trailing)
P/E (forward)
EPS (trailing)
Dividend yield
Beta
Avg. volume

Lite Strategy Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • LITS
    Lite Strategy Inc. Common Stock
    $0.98
    ▼ 2.00%
    Market cap $33.39MP/E
  • LTRN
    Lantern Pharma Inc. Common Stock
    $2.08
    ▼ 3.70%
    Market cap $33.30MP/E
    $1.11$4.7
  • IXHL
    Incannex Healthcare Inc. Common Stock
    $3.61
    ▼ 2.17%
    Market cap $35.06MP/E
    $2.49$20.64
  • ENLV
    Enlivex Ltd. Ordinary Shares
    $1.35
    ▼ 8.47%
    Market cap $36.53MP/E 0.02
    $1.35$27.15
  • APLM
    Apollomics Inc. Class A Ordinary Shares
    $26.6
    ▲ 1.14%
    Market cap $37.33MP/E
    $3.66$42.12
  • BCTX
    BriaCell Therapeutics Corp. Common Shares
    $3.73
    ▲ 0.54%
    Market cap $29.23MP/E
    $3.68$20.4
  • RMTI
    Rockwell Medical Inc. Common Stock
    $8.22
    ▲ 6.06%
    Market cap $28.54MP/E
    $4.89$21

P/E shows — for peers not currently carrying a live signal of their own.

Insider Activity

Insider Actions
Acquired
25.0K
Disposed
0

Institutional Ownership

March 31, 2026

Total shares held
5.75M
Total value held
$6.67M
Institutional holders
33
Top holders this quarter
  • Unknown1.74M
  • Unknown1.04M
  • Unknown767.5K
  • Unknown614.4K
  • Unknown401.1K
  • Unknown333.5K
  • Unknown157.9K
  • Unknown136.0K
  • Unknown115.0K
  • Unknown80.2K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.